Lates News

date
05/02/2026
On Wednesday, Lai's stock price surged 7.2% in early trading. The company announced a fourth-quarter revenue of $19.29 billion, adjusted earnings per share of $7.54, and raised its revenue guidance for 2026 to $80-83 billion and earnings per share guidance to $33.50-35.00 with the driving force of Zepbound and Mounjaro.